Drawing from a wide area of expertise, the Xenobics team have a proven track record in the production of antibodies and diagnostic solutions for the agri-food industry.

Professor Chris Elliot

Professor Chris Elliott

Founder and Board Member

Chris is currently the director of the Institute for Global Food Security at Queen’s University Belfast. Since 1986 Chris has been active in research related to the detection of contaminants and toxins in food and agricultural commodities using immunochemical based screening technologies.

Chris has co-ordinated and participated in many local and internationally funded research projects including the EU funded projects BioCop and QSAFFE. He has published more than 180 papers on detection and control of chemical contaminants in agri-food. In 2013, following the horsemeat scandal, Chris was appointed by HM Government to review the Integrity and assurance of Food Supply Networks. His report was published in 2014.

 

Queens Profile
ResearchGate Profile
LinkedIn Profile
Dr Katrina Campbell

Dr Katrina Campbell

Founder

Katrina is a lecturer in Bioanalytical Systems and heads the Biosensors Strand within the ASSET Centre within the Institute for Global Food Security at Queen’s University Belfast. Katrina has extensive experience in the production of immunological diagnostic reagents, bioanalytical method development, validation and evaluation of ELISA, lateral flow devices and biosensor technologies. She has been actively involved in many local and internationally funded research projects including BioCop, Conffidence, Midtal, Atlantox, MicroAqua, Handhold, Ciguatools and Collab4safety.

 

Queens Profile
ResearchGate Profile
LinkedIn Profile
Dr Brian Green

Dr Brian Green

Founder

Brian is senior lecturer in Molecular Nutrition at Queen’s University Belfast. Brian has worked on a number of academic and industry-led projects which relate to the development and testing of novel pharmaceuticals and nutraceuticals for treatment of degenerative diseases such as diabetes, obesity and cardiovascular disease. He has more than 100 high-impact factor peer-reviewed publications and is currently researching the application of metabolomics technologies for the study and diagnosis of human disease, particularly neurodegenerative diseases.

 

Queens Profile
ResearchGate Profile
QUBIS logo

QUBIS

Partner

Working with academic entrepreneurs, QUBIS have grown a portfolio of shareholdings in viable companies for over 27 years. These have succeeded on an international level.

QUBIS is represented by Mr Brian McCaul. A chemical engineer by profession, Pat has spent the last twenty years of his career as a director and shareholder in a number of hi-tech companies. He has participated as an angel investor, and his present business interests centre on the promotion of spin-out companies from universities.

 

Top